Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

RELA (RELA proto-oncogene, NF-kB subunit) (V-rel reticuloendotheliosis viral oncogene homolog A (Avian))

 Q7TQN4_RAT              Unreviewed;       550 AA.
Q7TQN4;
01-OCT-2003, integrated into UniProtKB/TrEMBL.
01-OCT-2003, sequence version 1.
25-OCT-2017, entry version 124.
SubName: Full=RELA {ECO:0000313|EMBL:AAP72180.1};
SubName: Full=RELA proto-oncogene, NF-kB subunit {ECO:0000313|Ensembl:ENSRNOP00000044552};
SubName: Full=V-rel reticuloendotheliosis viral oncogene homolog A (Avian) {ECO:0000313|EMBL:AAH79457.1};
Name=Rela {ECO:0000313|EMBL:AAH79457.1,
ECO:0000313|Ensembl:ENSRNOP00000044552, ECO:0000313|RGD:727889};
Synonyms=RelA {ECO:0000313|EMBL:AAP72180.1};
ORFNames=rCG_48632 {ECO:0000313|EMBL:EDM12513.1};
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
NCBI_TaxID=10116 {ECO:0000313|EMBL:AAP72180.1};
[1] {ECO:0000313|EMBL:AAP72180.1}
NUCLEOTIDE SEQUENCE.
STRAIN=Sprague-Dawley {ECO:0000313|EMBL:AAP72180.1};
Mao X., Barger S.W.;
"Cloning RelA gene from rat microglia and cortical neurons.";
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
[2] {ECO:0000313|EMBL:AAH79457.1}
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lung {ECO:0000313|EMBL:AAH79457.1};
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
Makowski K.A., Bosak S., Malek J.;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[3] {ECO:0000313|Ensembl:ENSRNOP00000044552, ECO:0000313|Proteomes:UP000002494}
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=Brown Norway {ECO:0000313|Ensembl:ENSRNOP00000044552,
ECO:0000313|Proteomes:UP000002494};
PubMed=15057822; DOI=10.1038/nature02426;
Rat Genome Sequencing Project Consortium;
Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T.,
Smith D., Lee H.-M., Gustafson E., Cahill P., Kana A.,
Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M.,
Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K.,
Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S.,
Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J.,
Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y.,
Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A.,
Ren Y., Song X.-Z., Li B., Liu Y., Qin X., Cawley S., Cooney A.J.,
D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R.,
Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A.,
Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E.,
Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E.,
Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D.,
Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M.,
Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O.,
Poliakov A., Huebner N., Ganten D., Goesele C., Hummel O.,
Kreitler T., Lee Y.-A., Monti J., Schulz H., Zimdahl H.,
Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S.,
Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J.,
Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E.,
Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F.,
Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K.,
Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S.,
Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M.,
Clarke L., Curwen V., Durbin R.M., Eyras E., Searle S.M., Cooper G.M.,
Batzoglou S., Brudno M., Sidow A., Stone E.A., Payseur B.A.,
Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S.,
Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G.,
Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H.,
Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R.,
Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M.,
Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H.,
Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S.,
Collins F.S.;
"Genome sequence of the Brown Norway rat yields insights into
mammalian evolution.";
Nature 428:493-521(2004).
[4] {ECO:0000313|EMBL:EDM12513.1}
NUCLEOTIDE SEQUENCE.
STRAIN=BN {ECO:0000313|EMBL:EDM12513.1};
PubMed=15632090; DOI=10.1101/gr.2889405;
Florea L., Di Francesco V., Miller J., Turner R., Yao A., Harris M.,
Walenz B., Mobarry C., Merkulov G.V., Charlab R., Dew I., Deng Z.,
Istrail S., Li P., Sutton G.;
"Gene and alternative splicing annotation with AIR.";
Genome Res. 15:54-66(2005).
[5] {ECO:0000313|EMBL:EDM12513.1}
NUCLEOTIDE SEQUENCE.
STRAIN=BN {ECO:0000313|EMBL:EDM12513.1};
Mural R.J., Li P.W., Adams M.D., Amanatides P.G., Baden-Tillson H.,
Barnstead M., Chin S.H., Dew I., Evans C.A., Ferriera S., Flanigan M.,
Fosler C., Glodek A., Gu Z., Holt R.A., Jennings D., Kraft C.L.,
Lu F., Nguyen T., Nusskern D.R., Pfannkoch C.M., Sitter C.,
Sutton G.G., Venter J.C., Wang Z., Woodage T., Zheng X.H., Zhong F.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[6] {ECO:0000313|Ensembl:ENSRNOP00000044552}
IDENTIFICATION.
STRAIN=Brown Norway {ECO:0000313|Ensembl:ENSRNOP00000044552};
Ensembl;
Submitted (FEB-2012) to UniProtKB.
-!- INTERACTION:
Q06518:Nos2; NbExp=3; IntAct=EBI-1187180, EBI-15919967;
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AC134224; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC079457; AAH79457.1; -; mRNA.
EMBL; AY307375; AAP72180.1; -; mRNA.
EMBL; CH473953; EDM12513.1; -; Genomic_DNA.
RefSeq; NP_954888.1; NM_199267.2.
UniGene; Rn.19480; -.
DIP; DIP-38953N; -.
IntAct; Q7TQN4; 6.
STRING; 10116.ENSRNOP00000044552; -.
Ensembl; ENSRNOT00000045233; ENSRNOP00000044552; ENSRNOG00000030888.
GeneID; 309165; -.
KEGG; rno:309165; -.
UCSC; RGD:727889; rat.
CTD; 5970; -.
RGD; 727889; Rela.
eggNOG; ENOG410IG8F; Eukaryota.
eggNOG; ENOG410XT64; LUCA.
GeneTree; ENSGT00500000044765; -.
HOGENOM; HOG000230474; -.
HOVERGEN; HBG017916; -.
KO; K04735; -.
OMA; EFSPMVF; -.
OrthoDB; EOG091G08JD; -.
TreeFam; TF325632; -.
Reactome; R-RNO-1169091; Activation of NF-kappaB in B cells.
Reactome; R-RNO-1810476; RIP-mediated NFkB activation via ZBP1.
Reactome; R-RNO-193692; Regulated proteolysis of p75NTR.
Reactome; R-RNO-202424; Downstream TCR signaling.
Reactome; R-RNO-209560; NF-kB is activated and signals survival.
Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
Reactome; R-RNO-3134963; DEx/H-box helicases activate type I IFN and inflammatory cytokines production.
Reactome; R-RNO-3214841; PKMTs methylate histone lysines.
Reactome; R-RNO-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
Reactome; R-RNO-446652; Interleukin-1 family signaling.
Reactome; R-RNO-448706; Interleukin-1 processing.
Reactome; R-RNO-5607764; CLEC7A (Dectin-1) signaling.
Reactome; R-RNO-5621575; CD209 (DC-SIGN) signaling.
Reactome; R-RNO-933542; TRAF6 mediated NF-kB activation.
Proteomes; UP000002494; Chromosome 1.
Bgee; ENSRNOG00000030888; -.
GO; GO:0005737; C:cytoplasm; IDA:RGD.
GO; GO:0005829; C:cytosol; IDA:RGD.
GO; GO:0033256; C:I-kappaB/NF-kappaB complex; IBA:GO_Central.
GO; GO:0035525; C:NF-kappaB p50/p65 complex; IEA:Ensembl.
GO; GO:0000790; C:nuclear chromatin; IDA:ParkinsonsUK-UCL.
GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
GO; GO:0043234; C:protein complex; IDA:RGD.
GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
GO; GO:0042805; F:actinin binding; IEA:Ensembl.
GO; GO:0033613; F:activating transcription factor binding; IEA:Ensembl.
GO; GO:0071532; F:ankyrin repeat binding; IEA:Ensembl.
GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
GO; GO:0001046; F:core promoter sequence-specific DNA binding; IDA:ParkinsonsUK-UCL.
GO; GO:0042826; F:histone deacetylase binding; IEA:Ensembl.
GO; GO:0051059; F:NF-kappaB binding; IEA:Ensembl.
GO; GO:0042301; F:phosphate ion binding; IEA:Ensembl.
GO; GO:0032403; F:protein complex binding; IPI:RGD.
GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
GO; GO:0047485; F:protein N-terminus binding; IEA:Ensembl.
GO; GO:0070491; F:repressing transcription factor binding; IEA:Ensembl.
GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IBA:GO_Central.
GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
GO; GO:0000983; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; IEA:Ensembl.
GO; GO:0008134; F:transcription factor binding; IPI:RGD.
GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
GO; GO:0006117; P:acetaldehyde metabolic process; IEP:RGD.
GO; GO:0007568; P:aging; IEP:RGD.
GO; GO:0009887; P:animal organ morphogenesis; IEA:Ensembl.
GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEA:Ensembl.
GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
GO; GO:0071354; P:cellular response to interleukin-6; IEA:Ensembl.
GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:RGD.
GO; GO:0071223; P:cellular response to lipoteichoic acid; IEA:Ensembl.
GO; GO:0071316; P:cellular response to nicotine; IEA:Ensembl.
GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl.
GO; GO:0071224; P:cellular response to peptidoglycan; IEA:Ensembl.
GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IBA:GO_Central.
GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
GO; GO:0045087; P:innate immune response; IBA:GO_Central.
GO; GO:0001889; P:liver development; IEA:Ensembl.
GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl.
GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:RGD.
GO; GO:1901223; P:negative regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
GO; GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl.
GO; GO:0033234; P:negative regulation of protein sumoylation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
GO; GO:0038061; P:NIK/NF-kappaB signaling; IBA:GO_Central.
GO; GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IEA:Ensembl.
GO; GO:0008284; P:positive regulation of cell proliferation; IMP:RGD.
GO; GO:0032332; P:positive regulation of chondrocyte differentiation; IMP:RGD.
GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
GO; GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IEA:Ensembl.
GO; GO:2000630; P:positive regulation of miRNA metabolic process; IEA:Ensembl.
GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
GO; GO:1902895; P:positive regulation of pri-miRNA transcription from RNA polymerase II promoter; IMP:BHF-UCL.
GO; GO:0014040; P:positive regulation of Schwann cell differentiation; IMP:RGD.
GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
GO; GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; IEA:Ensembl.
GO; GO:0043620; P:regulation of DNA-templated transcription in response to stress; IEA:Ensembl.
GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
GO; GO:0043200; P:response to amino acid; IEP:RGD.
GO; GO:0051591; P:response to cAMP; IEP:RGD.
GO; GO:0033590; P:response to cobalamin; IEP:RGD.
GO; GO:0034097; P:response to cytokine; IEP:RGD.
GO; GO:0042493; P:response to drug; IEP:RGD.
GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
GO; GO:0010035; P:response to inorganic substance; IEP:RGD.
GO; GO:0032868; P:response to insulin; IEP:RGD.
GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
GO; GO:0043278; P:response to morphine; IEP:RGD.
GO; GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl.
GO; GO:0035994; P:response to muscle stretch; IEA:Ensembl.
GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
GO; GO:0010033; P:response to organic substance; IEP:RGD.
GO; GO:0032570; P:response to progesterone; IEP:RGD.
GO; GO:0010224; P:response to UV-B; IEA:Ensembl.
GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IEA:Ensembl.
CDD; cd01177; IPT_NFkappaB; 1.
Gene3D; 2.60.40.10; -; 1.
Gene3D; 2.60.40.340; -; 1.
InterPro; IPR013783; Ig-like_fold.
InterPro; IPR014756; Ig_E-set.
InterPro; IPR002909; IPT.
InterPro; IPR033926; IPT_NFkappaB.
InterPro; IPR000451; NFkB/Dor.
InterPro; IPR008967; p53-like_TF_DNA-bd.
InterPro; IPR030495; RelA.
InterPro; IPR030492; RHD_CS.
InterPro; IPR032397; RHD_dimer.
InterPro; IPR011539; RHD_DNA_bind_dom.
InterPro; IPR037059; RHD_DNA_bind_dom_sf.
PANTHER; PTHR24169; PTHR24169; 1.
PANTHER; PTHR24169:SF1; PTHR24169:SF1; 1.
Pfam; PF16179; RHD_dimer; 1.
Pfam; PF00554; RHD_DNA_bind; 1.
PRINTS; PR00057; NFKBTNSCPFCT.
SMART; SM00429; IPT; 1.
SUPFAM; SSF49417; SSF49417; 1.
SUPFAM; SSF81296; SSF81296; 1.
PROSITE; PS01204; REL_1; 1.
PROSITE; PS50254; REL_2; 1.
1: Evidence at protein level;
Complete proteome {ECO:0000313|Proteomes:UP000002494};
Proteomics identification {ECO:0000213|PeptideAtlas:Q7TQN4};
Reference proteome {ECO:0000313|Proteomes:UP000002494}.
DOMAIN 16 190 RHD. {ECO:0000259|PROSITE:PS50254}.
SEQUENCE 550 AA; 60267 MW; 2C6A8FD68F667A64 CRC64;
MDDLFPLIFP SEPAQASGPY VEIIEQPKQR GMRFRYKCEG RSAGSIPGER STDTTKTHPT
IKINGYTGPG TVRISLVTKD PPHRPHPHEL VGKDCRDGFY EAELCPDRCI HSFQNLGIQC
VKKRDLEQAI SQRIQTNNNP FQVPIEEQRG DYDLNAVRLC FQVTVRDPSG RPLRLTPVLS
HPIFDNRAPN TAELKICRVN RNSGSCLGGD EIFLLCDKVQ KEDIEVYFTG PGWEARGSFS
QADVHRQVAI VFRTPPYADP SLQAPVRVSM QLRRPSDREL SEPMEFQYLP DTDDRHRIEE
KRKRTYETFK SIMKKSPFNG PTEPRPPPRR IAVPSRGPTS VPKPAPQPYA FSTSLSTINF
DEFSPMVLPP GQISNQALAL APSSAPVLAQ TMVPSSAMVP SLAQPPAPVP VLAPGPPQSL
SAPVPKSTQA GEGTLSEALL HLQFDADEDL GALLGNNTDP GVFTDLASVD NSEFQQLLNQ
GVAMSHSTAE PMLMEYPEAI TRLVTGSQRP PDPAPATLGT SGLPNGLSGD EDFSSIADMD
FSALLSQISS


Related products :

Catalog number Product name Quantity
RELA RELA Gene v-rel reticuloendotheliosis viral oncogene homolog A (avian)
10-P1669 Polyclonal antibody Anti-V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A, RELA 100μg
DL-RELA-Hu Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) ELISA Kit 96T
DL-RELA-Mu Mouse V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) ELISA Kit 96T
DL-RELA-Ra Rat V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) ELISA Kit 96T
201-20-4844 RELA{Homo sapiens v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian),}rabbit.pAb 0.2ml
CSB-EL019553CH Chicken v-rel reticuloendotheliosis viral oncogene homolog A (avian) (RELA) ELISA kit, Species Chicken, Sample Type serum, plasma 96T
201-11-1576 Rat V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
E90616Ra ELISA Kit for V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) 96T/Kit
UB-E10070 Rat V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
I1685 V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA), Rat, ELISA Kit 96T
E90616Mu ELISA Kit for V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) 96T/Kit
E90616Hu ELISA Kit for V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) 96T/Kit
QY-E10070 Rat V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
201-12-2620 Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)ELISA Kit 48T
QY-E04485 Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
201-12-2620 Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)ELISA Kit 96T
UB-E04485 Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
201-02-1118 Mouse V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
E2619Hu Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)ELISA Kit 48T
YHB3223Hu Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)ELISA Kit 48T
E2619Hu Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)ELISA Kit 96T
YHB3223Hu Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)ELISA Kit 96T
UB-E21617 Mouse V-Rel Reticuloendotheliosis Viral Oncogene Homolog A(RELA)ELISA Kit 96T
UT-E04485 Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA) ELISA Kit 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur